Topic: Medical Drug Therapy
Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. The company said an independent monitoring committee recommended stopping the study. It concluded that figitumumab in conjunction with Tarceva ...
Watson Pharmaceuticals Inc. said the Food and Drug Administration approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month doses. Trelstar is developed by Debiopharm Group of Switzerland and marketed by Watson. Watson plans to launch the six-month dose in ...
Hormone replacement therapy, now more commonly known as hormone therapy, use to be medical worlds standard treatment for those women suffering from hot flashes and other side effects of going through menopause. They also thought that it could help prevent osteoporosis and even heart disease.
In 2002 however; the minds of many in the medical field changed when they saw ...
Missouri selected a company Monday to develop a database for tracking purchases of cold medicine that can be used to make methamphetamine. Since 2005, Missouri has kept a paper log that law officers can check later to track purchases of cold medications containing pseudoephedrine ...
